For Investors

• Analyst Coverage
• Annual Reports
• Calendar
• Contact Investor Relations
• Financial Reports
• Frequently Asked Questions
• Management and Investor Relations
• Media Coverage
• News Releases
• Presentations
• Request Documents
• SEDAR Filings
• Stock Quote
• Webcasts
• Why Invest?

News Releases ::

• Isotechnika announces first sale of commercial supply of voclosporin
  More...October 6, 2008
  
• Isotechnika selected to present at international transplantation conference
  More...September 24, 2008
  
• Isotechnika hires advisors to advance strategic alternatives
  More...August 27, 2008
  

Media Coverage ::

• Isotechnika reports positive Phase 2b trial of voclosporin kidney-transplant drug
  More...May 27, 2008
• Voclosporin reduces plaques, has fewer side effects than cyclosporine
  More...May 5, 2008
• Voclosporin (ISA247) psoriasis trial shows impressive results
  More...April 18, 2008

Annual Reports

1999 Annual Report (PDF 2.83 MB)

2000 Annual Report (PDF 1.29 MB)

2001 Annual Report (PDF 2.05 MB)

2002 Annual Report (PDF 431 KB)

2003 Annual Report (PDF 459 KB)

2004 Annual Report (PDF 3.67 MB) (Web Version)

2005 Annual Report (PDF 989 KB)

2006 Annual Report (PDF 2.21 MB)

2007 Annual Report (PDF 2.59 MB)